English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

The interleukin-5 (IL-5)-IL-5-receptor system has been of great interest because the IL-5-receptor (IL-5R) contains the common cytokine-receptor β-chain (βc), which is shared with the GM-CSF receptor and IL-3 receptor. IL-5 is produced by type 2 T helper cells (Th2), mast cells, and eosinophils, and non-hematopoietic cells. As we discuss, IL-5 has pleiotropic actions, from enhancing the homeostatic proliferation and survival of B-1 cells through noncognate stimulation and driving the differentiation of B-1 and B-2 cells into terminally differentiated plasma cells to augmenting the survival and activation of eosinophils. Thus, IL-5 links natural and adaptive immunity specific to the epitopes of natural ligands and exogenous antigens leading to the inducion of Ig-producing cells, regulating chronic inflammation and controlling disease. The potential roles of IL-5 in immune responses, allergy and autoimmunity make it attractive candidate for use in the clinical setting. Rec.9/21/2005, pp482-491

Interleukin-5: Modulator of innate and acquired immunity